Chromosomes in lymphomas and solid tumors

Cancer Investigation

Volumn 16, Issue 3, 1998, Pages 183-187

  Heerema, Nyla A ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGENESIS; CHILDHOOD CANCER; CHROMOSOME TRANSLOCATION; CYTOGENETICS; HUMAN; LYMPHOMA; PRIORITY JOURNAL; REVIEW; SOLID TUMOR;

EID: 0031945598     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909809050035     Document Type: Review

References (70)

1. Juneja S, Lukeis R, Tan L, et al: Cytogenetic analysis of 147 cases of non-Hodgkin's lymphoma: Non-random chromosomal abnormalities and histological correlations. Br J Haematol 76:231-237, 1990.
2. Offit K: Chromosome analysis in the management of patients with non-Hodgkin's lymphoma. Leuk Lymphoma 7:275-282, 1992.
3. Offit K, Wong G, Filippa D, et al: Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Clinical correlations. Blood 77:1508-1515, 1991.
4. Tsujimoto Y, Finger LR, Yunis J, et al: Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226:1097-1099, 1984.
5. Vandenberghe E, De Wolf-Peeters C, van den Oord J, et al: Translocation (11;14): A Cytogenetic anomaly associated with B-cell lymphomas of non-follicle centre cell lineage. J Pathol 163:13-18, 1991.
6. Rimokh R, Berger F, Delsol G, et al: Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias. Blood 81:3063-3067, 1993.
7. Hirama T, Koeffler HP: Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86:841-854, 1995.
8. Schuuring E, Verhoeven E, Mooi WJ, et al: Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7:355-361, 1992.
9. Jiang W, Zhang YJ, Kahn SM, et al: Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA 90:9026-9030, 1993.
10. Nishida N, Fukuda Y, Komeda T, et al: Amplification and overexpression of the cyclin Dl gene in aggressive human hepatocellular carcinoma. Cancer Res 54:3107-3110, 1994.
11. Callender T, el-Naggar AK, Lee MS, et al: PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 74:152-158, 1994.
12. Bitter MA, Franklin WA, Larson RA, et al: Morphology in Ki-1(CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am J Surg Pathol 14:305-316, 1990.
13. Kaneko Y, Frizzera G, Edamura S, et al: A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood 73:806-813, 1989.
14. Shulman LN, Frisard B, Antin JH, et al: Primary Ki-1 anaplastic large-cell lymphoma in adults: Clinical characteristics and therapeutic outcome. J Clin Oncol 11:937-942, 1993.
15. Downing JR, Shurtleff SA, Zielenska M, et al: Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood 85:3416-3422, 1995.
16. Morris SW, Kirstein MN, Valentine MB, et al: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1281-1284, 1994.
17. Tilly H, Bastard C, Delastre T, et al: Cytogenetic studies in untreated Hodgkin's disease. Blood 77:1298-1304, 1991.
18. Döhner H, Bloomfield CD, Frizzera G, et al: Recurring chromosome abnormalities in Hodgkin's disease. Genes Chromosomes Cancer 5:392-398, 1992.
19. Weber-Matthiesen K, Deerberg J, Poetsch M, et al: Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease. Blood 86:1461-1468, 1995.
20. Mitelman, F: Catalog of Chromosome Aberrations in Cancer, 5th ed, New York, Wiley-Liss, 1994.
21. Whang-Peng J, Triche TJ, Knutsen T, et al: Chromosome translocation in peripheral neuroepithelioma. N Engl J Med 311:584-585, 1984.
22. Whang-Peng J, Triche TJ, Knutsen T, et al: Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet Cytogenet 21:185-208, 1987.
23. Whang-Peng J, Freter CE, Knutsen T, et al: Translocation t(11;22) in esthesioneuroblastoma. Cancer Genet Cytogenet 27:155-157, 1987.
24. Zucman J, Delattre O, Desmaze C, et al: Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints. Genes Chromosomes Cancer 5:271-277, 1992.
25. May WA, Gishizsky ML, Lessnick SL, et al: Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLU for transformation. Proc Natl Acad Sci USA 90:5752-5756, 1993.
26. Sorensen PHB, Lessnick SL, Lopez-Terrada D, et al: A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nature Genet 6:146-151, 1994.
27. Zucman J, Delattre O, Desmaze C, et al: EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nature Genet 4:341-345, 1993.
28. Ladanyi M, Gerald W: Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res 54:2837-2840, 1994.
29. Douglass EC, Valentine M, Etcubanas E, et al: A specific chromosomal abnormality in rhabdomyosarcoma. Cytogenet Cell Genet 45:148-155, 1987.
30. Barr FG, Galili N, Holick J, et al: Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nature Genet 3:113-117, 1993.
31. Shapiro DN, Sublett JE, Li B, et al: Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res 53:5108-5112, 1993.
32. Galili N, Davis RJ, Fredericks WJ, et al: Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nature Genet 5:230-235, 1993.
33. Douglass EC, Shapiro DN, Valentine M, et al: Alveolar rhabdomyosarcoma with the t(2;13): Cytogenetic findings and clinicopathologic correlations. Med Pediatr Oncol 21:83-87, 1993.
34. Brodeur GM: Neuroblastoma: Clinical significance of genetic abnormalities. Cancer Surv 9:673-688, 1992.
35. Mitani K, Kurosawa H, Suzuki A, et al: Amplification of N-myc in a rhabdomyosarcoma. Jpn J Cancer Res (Gann) 77:1062-1065, 1986.
36. Lee WH, Murphree AL, Benedict WF: Expression and amplification of the N-myc gene in primary retinoblastoma. Mature 309:458-460, 1984.
37. Nau MM, Brooks BJ, Carney DN, et al: Human small-cell lung cancers show amplification and expression of the N-myc gene. Proc Natl Acad Sci USA 83:1092-1096, 1986.
38. Zafrani B, Gerbault-Seureau M, Mosseri V, et al: Cytogenetic study of breast cancer: Clinicopathologic significance of homogeneously staining regions in 84 patients. Hum Pathol 23:542-547, 1992.
39. Kallioniemi A, Kallioniemi O-P, Piper J, et al: Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91:2156-2160, 1994.
40. Theillet C, Adelaide J, Louason G, et al: FGFR1 and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers. Genes Chromosomes Cancer 7:219-226, 1993.
41. Berns EM, Klijn JG, van Putten WL, et al: c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer. Cancer Res 552:1107-1113, 1992.
42. Karlseder J, Zeillinger R, Schneeberger C, et al: Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer. Genes Chromosomes Cancer 9:42-48, 1994.
43. Press MF, Pike MC, Chazin VR, et al: Her-2/neu expression in node-negative breast cancer: Direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Cancer Res 53:4960-4970, 1993.
44. Wright C, Angus B, Nicholson S, et al: Expression of c-erbB-2 oncoprotein: A prognostic indicator in human breast cancer. Cancer Res 49:2087-2090, 1989.
45. Borg Å, Baldetorp B, Ferno M, et al: c-myc amplification is an independent prognostic factor in postmenopausal breast cancer. Int J Cancer 51:687-691, 1992.
46. Arps S, Rodewald A, Schmalenberger B, et al: Cytogenetic survey of 32 cancers of the prostate. Cancer Genet Cytogenet 66:93-99, 1993.
47. Lundgren R, Mandahl N, Heim S, et al: Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosomes Cancer 4:16-24, 1992.
48. Micale MA, Mohamed A, Sakr W, et al: Cytogenetics of primary prostatic adenocarcinoma - Clonality and chromosome instability. Cancer Genet Cytogenet 61:165-173, 1992.
49. Johansson B, Heim S, Mandahl N, et al: Trisomy 7 in nonneoplastic cells. Genes Chromosomes Cancer 6:199-205, 1993.
50. Casalone R, Portentoso P, Granata P, et al: Chromosome changes in benign prostatic hyperplasia and their significance in the origin of prostatic carcinoma. Cancer Genet Cytogenet 68:126-130, 1993.
51. Aly MS, Dal Cin P, Van de Voorde W, et al: Chromosome abnormalities in benign prostatic hyperplasia. Genes Chromosomes Cancer 9:227-233, 1994.
52. Mitelman F, Kaneko Y, Trent J: Report of the committee on chromosome changes in neoplasia. Cytogenet Cell Genet 55:358-386, 1990.
53. Macoska JA, Trybus TM, Sakr WA, et al: Fuorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res 54:3824-3830, 1994.
54. Brothman AR, Patel AM, Peehl DM, et al: Analysis of prostatic tumor cultures using fluorescence in-situ hybridization (FISH). Cancer Genet Cytogenet 62:180-185, 1992.
55. Brothman AR: Molecular cytogenetic analysis of human prostate cancer. Cancer Genet Cytogenet 84:13, 1995 (abstract).
56. Jenkins R, Takahashi S, Brown J, et al: Chromosomal alterations detected by fluorescence in situ hybridization (FISH) in prostate cancer. Sixth International Workshop on Chromosomes in Solid Tumors 13, 1995 (abstract).
57. Visakorpi T, Hyytinen E, Koivisto P, et al: In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genet 9:401-406, 1995.
58. Loehrer PJ, Williams SD, Einhorn LH: Testicular cancer: The quest continues. J Natl Cancer Inst 80:1373-1382, 1988.
59. de Jong B, Oosterhuis JW, Castedo SMMJ, et al: Pathogenesis of adult testicular germ cell tumors. A cytogenetic model. Cancer Genet Cytogenet 48:143-167, 1990.
60. Chaganti RSK, Rodriguez E, Bosl GJ: Cytogenetics of male germ cell tumors. Urol Clin North Am 20:55-66, 1993.
61. Smolarek TA, Blough RI, Foster RS, et al: Identification of multiple chromosome 12 abnormalities in human testicular germ cell tumors by two-color fluorescence in situ hybridization (FISH). Genes Chromosomes Cancer 14:252-258, 1995.
62. Suijkerbuijk RF, Sinke RJ, Meloni AM, et al: Overrepresentation of chromosome 12p sequences and karyotypic evolution in i(12p)-negative testicular germ-cell tumors revealed by fluorescence in situ hybridization. Cancer Genet Cytogenet 70:85-93, 1993.
63. Smolarek, TA: Cytogenetic and molecular cytogenetic analyses of untreated testicular germ cell tumors, Ph.D. thesis, Indiana University, 1995.
64. Samaniego F, Rodriguez E, Holdsworth J, et al: Cytogenetic and molecular analysis of human male germ cell tumors. Chromosome 12 abnormalities and gene amplification. Genes Chromosomes Cancer 1:289-300, 1990.
65. Zang KD: Cytological and cytogenetical studies on human meningioma. Cancer Genet Cytogenet 6:249-274, 1982.
66. Mrozek K, Karakousis CP, Bloomfield CD: Chromosome 12 breakpoints are cytogenetically different in benign and malignant lipogenic tumors: localization of breakpoints in lipoma to 12q15 and in myxoid liposarcoma to 12q13.3. Cancer Res 53:1670-1675, 1993.
67. Mandahl N, Heim S, Arheden K, et al: Three major cytogenetic subgroups can be identified among chromosomally abnormal solitary lipomas. Hum Genet 79:203-208, 1988.
68. Nilbert M, Heim S, Mandahl N, et al: Karyotypic rearrangements in 20 uterine leiomyomas. Cytogenet Cell Genet 49:100-104, 1988.
69. Mark J, Sandros J, Wedell B, et al: Significance of the choice of tissue culture technique on the chromosomal patterns in human mixed salivary gland tumors. Cancer Genet Cytogenet 33:229-244, 1988.
70. Vogelstein B, Kanzler KW: The multistep nature of cancer. Trends in Genetics 9:138-141, 1993.